《公司業績》美高梅中國(02282.HK)中期虧損28.6億元 盈轉虧
美高梅中國(02282.HK)公布6月止六個月中期業績,錄得虧損28.6億元,相對2019年同期純利10.22億元,盈轉虧,歸因與COVID-19疫情相關的設施關閉及各種限制令上半年活動大幅減少;每股虧損75.3仙。經調整EBITDA虧損10.08億元。不派中期息。
期內,經營收入23.7億元,減少79%。其中,娛樂場收益20.45億元,減少79.9%;貴賓賭檯總贏額減少81.1%至9.34億元、主場地賭檯總贏額減少78.2%至15.45億元、角子機總贏額減少75.2%至2.72億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.